Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

When Rheumatology and Cancer Collide

Simon M. Helfgott, MD  |  Issue: March 2015  |  March 1, 2015

When Rheumatology and Cancer Collide
Each encounter began with Maria exhorting me to start eating the cannoli they had brought especially for me.

What a delightful couple: Maria, the highly caffeinated, chain-smoking, raspy voiced lady with severe rheumatoid arthritis (RA), and Vinny, her adoring nephew and personal chauffeur who faithfully accompanied her on every visit.

Each encounter began in much the same way: Maria, a waif of a woman with boundless energy, would tear into my office, plant a kiss on my cheek and proceed to wag a crooked finger, exhorting me to start eating the mouth-watering cannoli that Vinny had brought especially for me from their favorite Italian bakery in Boston’s North End. As I filled my mouth, she would start speaking a mile a minute, first inquiring about my family and which travel destinations I might be heading to. She would then proudly display the latest photos of her many adoring grandnieces and nephews, assiduously reciting their latest academic and athletic accomplishments. We would finally get down to the business at hand—how she was feeling.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Were the drugs helpful? Had she tried tapering off prednisone?

Maria was forever the optimist, having endured the consequences of living with poorly controlled RA. She was always hoping for some pot of gold—that new blockbuster drug that might transform her life.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This visit began in the same buoyant fashion as all the others, but it took an ominous turn after the pastries were consumed. Maria’s speech didn’t sound right; its usual rapid-fire tempo was punctuated by some very slight pauses, as though she needed to slow down and catch her breath. Apparently, I wasn’t the only one to have noticed this change. Vinny confided that he was growing alarmed that his aunt wasn’t keeping up with her activities as she usually did. It was his idea to move up the date of Maria’s scheduled appointment when he caught his aunt napping at the kitchen table.

As doctors, we are trained to look and observe. As rheumatologists, we often begin by looking at the hands. Sometimes they recite the patient’s story far more effectively than words. What I saw in Maria’s hands took my breath away. It wasn’t the swollen knuckles or her longstanding boutonnière finger deformities that alarmed me. It was the curious bulbous appearance of her fingertips portending the development of clubbing. Maria thought the odd shape developed literally overnight. Her hands were more painful than usual, which she assumed was just a part of her RA. Although the differential diagnosis of a lifelong smoker developing new clubbing and shortness of breath includes several infectious and cardiorespiratory possibilities, it seemed likely that one dire diagnosis would rise above the rest. This story was not going to have a happy ending.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:autoimmunityCancerDiagnosisHelfgottinflammationRheumatoid arthritis

Related Articles
    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    2014 ACR/ARHP Annual Meeting: Autoimmune Connective Tissue Diseases and Cancer

    April 1, 2015

    Links between autoimmunity, malignancy prompt rheumatologists to include cancer screening for patients

    Case Report: A Patient’s Clubbing & Arthralgias Resist Diagnosis

    April 15, 2020

    A 59-year-old woman presented to our rheumatology clinic with a six-month history of a symmetric polyarthritis. She initially experienced pain in both knees. As time progressed, she began to notice pain in her ankles, hips, shoulders, hands and feet. She experienced joint stiffness lasting for more than 30 minutes every morning. She also described worsening…

    Malignant Complications: Screening for Cancer in Rheumatic Diseases

    July 13, 2020

    Cancer and autoimmunity have a complex relationship. In a presentation, Ami Shah, MD, MHS, discussed how to use autoantibodies as tools for cancer risk stratification, how to approach cancer screening in individuals with new-onset disease and more…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences